147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Heln er beta cell line

The stably transfected luciferase reporter HELN Er alpha cell line (named HELN for HeLa-ERE-Luciferase-Neomycin) was obtained by transfection of ER […]

Heln er alpha cell line

Cervical cancer cell line HeLa (ER negative) firstly transfected by a luciferase firefly gene under the control of an estrogen responsive element […]

You might also be interested in